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Transgenic Expression of Syndecan-1
Uncovers a Physiological Control
of Feeding Behavior by Syndecan-3
hypothalamic systems, which detect and integrate pe-
ripheral signals and ultimately maintain energy balance
by altering feeding behavior and autonomic and neuro-
endocrine activities (Porte et al., 1998; Schwartz et al.,
2000; Spiegelman and Flier, 1996). Feeding behavior is
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Interactions between many signaling receptors andBiosciences
University of Helsinki their ligands are modulated by secreted and/or cell sur-
face molecules. A major group of these modulators areFinland 00014
cell surface heparan sulfate proteoglycans (HSPGs),
which bind a large number of extracellular ligands, in-
cluding ECM components, growth factors, cytokines,
chemokines, proteinases, proteinase inhibitors, lipopro-Summary
teins, and enzymes of lipid metabolism (Conrad, 1998).
The syndecans, a family of four transmembrane HSPGsTransgenic expression in the hypothalamus of synde-
can-1, a cell surface heparan sulfate proteoglycan in mammals, together with the members of the glypican
family of glycerophosphoinositol-linked HSPGs, ac-(HSPG) and modulator of ligand-receptor encounters,
produces mice with hyperphagia and maturity-onset count for nearly all the HS that is ubiquitous at cell
surfaces (Bernfield et al., 1999; Park et al., 2000). Synde-obesity resembling mice with reduced action ofmel-
anocyte stimulating hormone (MSH). Via their HS can family members are found on essentially every type
of adherent cell (Bernfield et al., 1999), but are differen-chains, syndecans potentiate the action of agouti-
related protein and agouti signaling protein, endoge- tially expressed on distinct cell types; e.g., syndecan-1
predominates on epithelia, whereas syndecan-3 pre-nous inhibitors of MSH. In wild-type mice, syndecan-3,
the predominantly neural syndecan, is expressed in dominates on neural crest derivatives and neurons. Syn-
decans are induced during development, tissue injury,hypothalamic regions that control energy balance.
Food deprivation increases hypothalamic syndecan-3 and in response to a variety of physiological stimuli
(Bernfield et al., 1999; Hsueh and Sheng, 1999; Lauri etlevels several-fold. Syndecan-3 null mice, otherwise
apparently normal, respond to food deprivation with al., 1998).
The extracellular domains of the syndecans are re-markedly reduced reflex hyperphagia. We propose
that oscillation of hypothalamic syndecan-3 levels leased from the cell surface by cleavage of the core
physiologically modulates feeding behavior. protein at a juxtamembrane site in a highly regulated
process called ectodomain shedding (Hooper et al.,
Introduction 1997). The shed soluble ectodomains retain all of the
HS of the parental cell surface HSPG, and thus may act
Mammalian evolution has provided multiple comple- in a paracrine manner, either as negative or positive
mentary mechanisms to ensure the exquisitely precise effectors. Shedding of syndecan-1 and -4 ectodomains
regulation of body weight (Bray and Tartaglia, 2000; is accelerated by activation of either G protein-coupled
Friedman, 2000). These homeostatic controls are mostly or protein tyrosine kinase signaling receptors (Subra-
manian et al., 1997), which in turn activate several down-
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Figure 1. Syndtrophin Mice Develop Maturity-Onset Obesity due to Hyperphagia
(a) Photograph showing obese male syndtrophin mouse at six months of age and its wild-type littermate.
(b) Body weights of male syndtrophin mice (SndA line) on the FVB strain. Body weights were measured weekly beginning at 10 days of life.
Values are mean  SEM. Snd/Snd (n  5), Snd/ (n  13), and / (n  5) mice.
(c and d) Obesity in syndtrophin mice is due to hyperphagia. Mice were individually housed in metabolic chambers (c) or standard cages (d)
and acclimated for one week. (c) Food and water consumption were monitored daily over a two week period. (d) Six-week-old male syndtrophin
mice were pair fed an amount of chow equivalent to ad libitum fed / 6-week-old male mice (5.5 g/chow day). Values are mean  SEM,
Snd/Snd 6 month old male (n  5), / (n  3), 6 week old male (n  5), and / (n  3), for pair feeding Snd/Snd (n  5), and / (n 
5) (†, p  0.05; ‡, p  0.005).
1984) and in response to pathophysiological events nist, potentiated its activity in a cell culture system and
interacted with its in vivo homolog, agouti signaling pro-(Park et al., 2000).
During the course of studies of syndecan function tein (ASP). Further, the transgenically misexpressed hy-
pothalamic syndecan-1 causes obesity only when at thein mice, we discovered that transgenic expression of
syndecan-1 under the control of the CMV promoter/ cell surface.
We hypothesized that transgenic misexpression ofenhancer yields high levels of syndecan-1 in multiple
somatic tissues and in specific regions of the brain syndecan-1 in the hypothalamus mimics a physiological
modulator of feeding behavior. In wild-type mice, wewhere it is not normally expressed. Transgenically ex-
pressed syndecan-1 was found in the hypothalamic nu- determined that syndecan-3, the predominantly neural
member of the syndecan family, localizes in regions ofclei that control energy balance, and was associated
with maturity-onset obesity. We named these mice syn- the hypothalamus that control energy balance, is shed
under physiological conditions, and that its level in-dtrophin from syndecan and from the Greek word trofis,
meaning well fed. The obesity phenotype of syndtrophin creases several-fold in response to food deprivation in
a manner identical to various anti-satiety neuropeptides.mice closely resembled that of mice with impaired action
of hypothalamic MSH, viz agouti lethal yellow (Ay), Finally, syndecan-3 null mice show markedly reduced
reflex hyperphagia following overnight food deprivation,transgenic agouti-related protein (Agrp), and melano-
cortin-4 receptor (MC-4R) null mice. Agrp (or ART), an directly implicating syndecan-3 in the control of feeding
behavior.endogenous hypothalamic peptide, competes with
MSH at the MC-3R and -4R (Ollmann et al., 1997; Shut-
ter et al., 1997). The melanocortin receptors are seven Results
pass transmembrane G protein-coupled receptors that
stimulate adenylyl cyclase and generate the second Generation of Syndecan-1 Transgenic Mice
Six lines of syndecan-1 transgenic mice were generatedmessenger cAMP (Cone et al., 1996). Consistent with
the phenotype of syndtrophin mice, we discovered that in FVB mice using the CMV promoter/enhancer. Three
transgenic lines FVB/N-TgN(Synd1)aMB (denotedsyndecan-1-bound Agrp, a hypothalamicMSH antago-
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Table 1. Physiological Analysis
Glucose Insulin Leptin Corticosterone
(mg/dl) (ng/ml) (ng/ml) (ng/ml)
6 weeks males n
/ 5 204  21 1.2  0.1 2.8  0.8 nd
Tg.Snd/Snd 5 250  45 1.2  0.4 3.2  0.5 nd
females
/ 5 180  25 1.5  0.5 1.9  0.4 nd
Tg.Snd/Snd 5 190  50 1.9  0.4 1.8  0.2 nd
6 months males
/ 6 176  25* 1.1  0.2‡ 3.1  0.2* 16.5  3.0
Tg.Snd/Snd 5 508  16* 64.3  19‡ 17.0  1.2* 20.0  0.7
females
/ 7 126  5† 0.4  0.2† 2.5  0.5† 29  8.0
Tg.Snd/Snd 6 248  54† 9.4  3.0 28.4  5.5‡ 30  8.0
nd  not determined, †  p  0.05, ‡  p  0.005, *  p  0.0001
Tg.SndA, Tg.SndB, and Tg.SndE) expressed the full- at 6 months, food consumption in males was 78% and
females 70% greater than their control littermates.length syndecan-1 cDNA, and three transgenic lines
These mice feed continuously, even during daylight(Tg.SndC, Tg.SndF, and Tg.SndG) expressed a transgene
hours. Pair feeding studies were undertaken to evaluatethat was identical except a stop codon was inserted 57
the contribution of food intake to weight gain (Figurebase pairs after the initiator methionine, resulting in a 19
1d). Six-week-old Snd/Snd male mice were fed a dietamino acid truncated protein (nontranslatable control).
equivalent to their / littermates (5.5 g chow per day)All transgenic mice were normal at birth in litter size and
for 2 weeks. While Snd/Snd mice on an unrestricted dietmorphology, and grew at a normal rate through sexual
continued to gain weight, their food restricted partnersmaturity. Whereas syndecan-1 is normally expressed in
showed no significant increase in weight. The lack ofnearly all parenchymal tissues, and is most prominent
weight gain on a pair fed diet suggests that the weightin epithelia (Bernfield et al., 1999), the transgene was
gain is primarily due to hyperphagia.even more widely expressed. Immunohistochemical
Syndtrophin mice accumulate fat in all adipose tissueanalysis of Tg.SndA/SndA, Tg.SndB/, and Tg.SndE/
depots as visualized by magnetic resonance imagingmice showed syndecan-1 overexpression in most epi-
(data not shown). Carcass analysis indicated that thethelial tissues and misexpression in several mesenchy-
increased weight was due to accumulation of neutralmal tissues, including adrenal, kidney, heart and skeletal
fat. Snd/Snd males contained 2.5-fold more triglyceridemuscle, and brain. Syndecan-1 was on cell surfaces in
while females contained 2.9-fold more triglyceride thanthese tissues with the exception of heart and skeletal
controls. Although the amount of total protein in themuscle where staining was intracellular. Syndecan-1
transgenic mice was increased (data not shown), totalprotein expression in tissues from nontranslatable con-
protein as a proportion of body weight was the sametrol lines Tg.SndC/SndC, Tg.SndF/, and Tg.Snd/G
as in the wild-type mice. All organs showed increasedwas identical to that in wild-type mice.
weight but only adipose tissue showed an increase that
was proportionately greater than the increase in body
Transgenic Expression of Syndecan-1 Leads weight. Snd/Snd mice showed a 10% increase in overall
to Maturity-Onset Obesity body length (data not shown). The proportional in-
At approximately 8 weeks, both homozygote and hemi- creases in organ weights and total protein and the in-
zygote Tg.SndA line mice begin to show increased body creased length suggest that lean body mass is not af-
weight (Figures 1a and 1b). While wild-type (/) mice fected in these mice.
plateau in weight, the transgenic mice continue to gain Syndtrophin mice show increased plasma leptin, insu-
weight throughout life, although at a reduced rate be- lin, and glucose levels (obese males) but normal cortico-
yond six months of age. Hemizygotes showed a weight sterone levels (Table 1). Glucose, insulin, and leptin lev-
gain intermediate between homozygotes and wild-type els at 6 weeks were normal but obese (6 month) Snd/
mice. The two additional lines (Tg.SndB and Tg.SndE) Snd males were hyperinsulinemic and hyperglycemic,
showed similar growth profiles (data not shown). Lines with glucose levels exceeding 500 mg/dl. Leptin levels
containing the nontranslatable syndecan-1 transgene correlated with the extent of obesity; levels were 5-fold
(Tg.SndC, Tg.SndF, and Tg.SndG) did not become over controls in males and greater than 10-fold in fe-
obese (data not shown). Because only data from the males (Table 1). The syndtrophin mouse phenotype, in-
Tg.SndA line are presented here, Snd/ and Snd/Snd cluding adult onset obesity, relatively unchanged lean
will be used to denote hemizygote and homozygote body mass, increased linear growth, generalized fat dis-
transgenic mice, respectively. tribution, and blood chemistry, is distinct from that seen
Weight gain in syndtrophin mice is predominantly due in ob/ob and db/db mice. Syndtrophin mice mimic the
to hyperphagia. Ad libitum food consumption was mea- phenotype seen in agouti Ay/a, Tg.Agrp, MC-4R null,
sured over a two week period in Snd/Snd and control and POMC null mice obesity syndromes, suggesting
mice at 6 weeks and 6 months of age (Figure 1c). At 6 the same underlying etiology, viz impaired hypothalamic
weeks of age, food consumption in males was 23% and MSH signaling. (Huszar et al., 1997; Ollmann et al.,
1997; Yaswen et al., 1999; Yen et al., 1994).females 17% greater than their control littermates, while
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Figure 2. Syndecan-1 Is Expressed in Hypothalamic Nuclei of Syndtrophin Mice
Protein and transcript expression patterns of syndecan-1 in the hypothalamus of Snd/Snd (SndA line) 6-month-old mice. (A) and (B) are
confocal images of coronal sections from Snd/Snd mice processed for double immunohistochemical labeling of syndecan-1 protein expression
(green) and the hypothalamic paraventricular nuclei marker oxytocin (red). (A) inset shows magnification of paraventricular nuclei. (C) and (D)
are serial sections processed for in situ hybridization using an antisense riboprobe specific for the syndecan-1 transcript. Representative
sections were taken from the anterior (A and C) or posterior (B and D) hypothalamus. arc, arcuate; dmh, dorsomedial hypothalamus; lha,
lateral hypothalamic area; pev, periventricular nuclei; pvn, paraventricular nuclei; scn, suprachiasmatic nuclei; son, supraoptic nuclei; and 3V,
third ventricle. Scale bar  250 m.
Syndtrophin Mice Express Syndecan-1 lar nuclei. Syndecan-1 staining was observed on the
surfaces of cell bodies and along fiber tracts (e.g., cen-in the Hypothalamic Nuclei that Regulate
Feeding and Energy Balance tral nuclei of the amygdala, paraventricular thalamic nu-
clei, median eminence, and the olfactory bulb) (data notDue to the phenotypic similarity of syndtrophin mice to
mice with impaired hypothalamic MSH signaling, we shown). Syndecan-1 mRNA was detected only in the
hypothalamus, and in an identical distribution as theevaluated the expression pattern of the wild-type gene
and the transgene in the brain. Immunohistochemical protein (Figures 2B and 2D). This expression was not
associated with morphological or light microscopicallyand in situ hybridization of/mice showed no endog-
enous syndecan-1 protein or mRNA expression in the identifiable histological abnormalities. The nontrans-
latable syndecan-1 transgene expressed syndecan-1brain (data not shown). However, both syndecan-1 protein
and mRNA were in the brains of syndtrophin mice, essen- mRNA in the same hypothalamic nuclei as the Snd/Snd
mice (data not shown), indicating that the hypothalamictially limited to certain hypothalamic nuclei and their pro-
jections (Figure 2). Identical expression patterns were localization of the mRNA is not secondary to the obesity
phenotype.seen in 6-week- and 6-month-old mice as well as in
Tg.SndB, and Tg.SndE lines. Anteriorly, syndecan-1 was
expressed in the paraventricular, suprachiasmatic, and Syndecans Modulate the Activity
of AGRP and ASPsupraoptic nuclei (Figures 2A and 2C), and posteriorly in
the dorsomedial, arcuate, and lateral area hypothalamic The phenotype and the hypothalamic localization of the
transgene suggested an interaction between syndecan-1nuclei (Figures 2B and 2D). Staining with oxytocin con-
firms that syndecan-1 localized to the paraventricular and a component of the MSH signaling pathway. Thus,
a ligand blot assay (Salmivirta et al., 1991) was usednuclei anteriorly (Figure 2A) (Paxinos, 1995). Oxytocin
immunoreactivity was also detected in the periventricu- to assess whether syndecan-1 interacts directly with
Hypothalamic Syndecan-3 Modulates Feeding Behavior
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Figure 3. Syndecan-1 HS Chains Bind and Potentiate the Activity of Agouti-Related Protein (Agrp) and Agouti Signaling Protein (ASP)
(a) Syndecan-1 binds to ASP and Agrp via its N-terminal region. Five nmol of FGF-2, Agrp (full-length), Agrp (C-terminal, approximately 50
amino acids), ASP (full length) as well as -melanocyte stimulating hormone (MSH), corticotropin releasing hormone (CRH), and leptin were
bound to nitrocellulose membranes. Blots were incubated overnight at 4C with [35S]syndecan-1 ectodomain, washed in PBS, dried, and
exposed for autoradiography.
(b) Via its HS chains, syndecan-1 interacts with Agrp under physiological salt conditions. Five nmol Agrp was bound to a nitrocellulose
membrane, incubated with [35S]syndecan-1 ectodomain in PBS at varying NaCl concentrations or with heparin (1000 ng/ml), and blots processed
as above.
(c) Cell surface syndecan-1 or -3 potentiate the action of Agrp. HEK293 cells expressing the human MC4-R were transiently transfected with
either syndecan-1, -3, or control (nontranslatable syndecan-1) cDNAs. To evaluate the effects of the syndecans, cells were incubated for 30
min with Agrp (1 nM), a suboptimal concentration to inhibit MSH or its stable analog NDP-MSH, then stimulated for 30 min with varying
concentrations of MSH and assayed for generation of cAMP. Data shown are for 100 nM MSH or NDPMSH and presented as mean 
SEM (n  3).
(d) Syndecan-1 potentiates the obesity of lethal yellow (Ay/a) mice. The syndecan-1 transgene was backcrossed into C57Bl/6J mice for 7
generations then intercrossed with Ay/a mice. Values are mean  SEM. Ay/a,Snd/ (n  5), Ay/a (n  6), Snd/ (n  6), and / (n  5).
known components of this pathway. Soluble syndecan-1 whether cell surface syndecans modulate this inhibition
of the MC-4R by Agrp, we transfected HEK 293 cellsectodomain from NMuMG cells was used because its
HS chains are similar in size (approximately 35 kDa) expressing hMC-4R (Lu et al., 1994; Ollmann et al., 1997)
with syndecan-1, -3 (the neural syndecan), or control(Jalkanen et al., 1985) to hypothalamic syndecan-1 from
syndtrophin mice and to brain syndecan-3 from wild- cDNA (containing nontranslatable syndecan-1 cDNA).
MC-4R activity was unaffected by the transfections ortype mice (Figures 4b and 5b). Syndecan-1-bound
FGF-2, but also ASP, and Agrp, but not NPY, leptin, by 1 nM concentration of Agrp (data not shown). To
evaluate the effects of cell surface syndecans, theMCH, CRH, and importantly, MSH (Figure 3a and data
not shown). Agrp (full-length, but not C-terminal domain) transfectants were treated with 100 nM MSH or its
stable analog NDP-MSH (100 nM), and assayed forand ASP both bind in a heparin- and salt-dependent
manner (Figures 3a and 3b). The affinity of the interaction cAMP generation in the presence or absence of 1 nM
Agrp, a concentration which does not affect MSH ac-could not be estimated because of limiting amounts of
full-length Agrp. tion in this assay. However, cells transfected with synde-
can-1 or -3 showed significant inhibition of MC-4R activ-Agrp is a competitive antagonist of MSH at the mela-
nocortin-3R and -4R (Ollmann et al., 1997). MSH bind- ity (Figure 3c), suggesting that cell surface syndecans
can potentiate the action of Agrp in cultured cells.ing to these receptors results in adenylyl cyclase activa-
tion and generation of intracellular cAMP. Ten to one Analogously, transgenically expressed syndecan-1
potentiates the action of ASP in vivo in double mutanthundred nM Agrp competitively inhibits MSH binding,
resulting in reduced cAMP accumulation. To evaluate Ay/a, Snd/ mice. C57Bl6J-Snd/(N7) mice develop
Cell
110
obesity less quickly than when the transgene is on the
FVB background; weight gain does not exceed that of
/ mice until 15–16 weeks (Figure 3d). Weight gain in
the Ay/a mice becomes abnormally rapid at approxi-
mately 6 weeks. However, the double mutant (Ay/a,
Snd/) mice begin to show increased weight gain at
approximately 4 weeks, and their weight gain prior to
16 weeks exceeds the sum of the weight gained by
the parental strains. Thus, mice bearing the syndecan-1
transgene gain weight more rapidly and to a greater
extent in Ay/a than in / mice, suggesting that trans-
genic syndecan-1 potentiates the obesity-inducing ac-
tion of hypothalamic ASP in vivo.
Cell Surface but Not Shed Syndecan-1
Produces Obesity
Syndecan-1 in most tissues is in two pools, one at the
cell surface and extractable solely with detergent, the
other shed as the soluble ectodomain and extractable
in the absence of detergent (Figure 4a). Hypothalamic
syndecan-1 in syndtrophin mice is solely extracted by
detergent and is not soluble (Figure 4b). After removal
of the GAG chains, hypothalamic syndecan-1 migrates
as a single band (80 kDa), while skin syndecan-1 mi-
grates as a double band, the smaller of which is the
soluble ectodomain (69 kDa) (Fitzgerald et al., 2000;
Subramanian et al., 1997). These data indicate that in
syndtrophin mice, a proportion of skin syndecan is the
Figure 4. Cell Surface Syndecan-1 in Hypothalamus Leads toshed, soluble syndecan-1 ectodomain, and that hypo-
Obesitythalamic syndecan-1 is not shed.
(a and b) Syndecan-1 is expressed at the cell surface and as aAdditional transgenic lines were generated to evaluate
soluble ectodomain in the skin (a) and solely at the cell surface in
the significance of ectodomain shedding: An uncleav- the hypothalamus (b) of syndtrophin mice. Aqueous (A) or detergent
able (UC) syndecan-1 was made by swapping the juxta- extracts (D) of Snd/Snd or / mice were either untreated (No Rx)
membrane 15 amino acids (E238GATGASQSLLDTKE252) or digested with heparin lyase I, heparin lyase III, and chondroitinase
ABC (Lyase). Samples were blotted with anti-syndecan-1 mono-of syndecan-1 with human CD4, which prevents shed-
clonal antibody. Approximately 5 g total protein was applied perding, and a constitutively shed (CS) syndecan-1 was
lane.made by inserting a stop codon in the juxtamembrane
(c) Cell surface expression of syndecan-1 results in obesity. Mutant
domain at amino acid Q245 (O.R., unpublished data). syndecan-1 cDNAs that code for solely a cell surface/uncleavable
These mutant constructs were tested by transfection (SndUC) syndecan-1 or a constitutively shed/secreted (SndCS) syn-
into CHO cells and shown to behave precisely as de- decan-1 were generated in FVB mice. Mutant mice were genotyped
as above and weight monitored weekly for 40 weeks. Data shownsigned (Fitzgerald et al., 2000; data not shown). Several
are for the hemizygotes SndUC/ (n  10), SndCS/ (n  10),lines of transgenic mice were generated on the FVB
Snd/ (n  13), and wild-type / (n  6).strain and three lines of each, shown by immunohisto-
chemical analyses to localize the transgene identically
as in syndtrophin mice, were selected for study (Figure could be the physiological analog of misexpressed syn-
4c). Western analyses indicated that in the hypothala- decan-1.
mus, the UC transgene expressed less well and the CS Immunostaining showed syndecan-3 in the hypothal-
transgene better than the syndecan-1 transgene (data amus of / mice (Figure 5a). Anteriorly, syndecan-3
not shown). Mice expressing the UC construct began was expressed in the paraventricular hypothalamic nu-
to gain weight excessively at 6 weeks, while the CS clei (panel A), and posteriorly in the lateral area hypothal-
mutants failed to become obese, gaining weight identi- amic nuclei (panel C). Paraventricular staining was con-
cally as their wild-type littermates. Thus, hypothalamic firmed by staining adjacent sections for oxytocin (panel
syndecan-1 generates obesity solely when at the cell B), though oxytocin staining was also observed in the
surface. periventricular nuclei (Paxinos, 1995). The syndecan-3
is detected on the surfaces of neuronal cell bodies and
projections (data not shown). Staining was blocked bySyndecan-3 Is Expressed in Hypothalamus
and Regulated by Feeding State preincubation with a GST-syndecan-3 fusion protein
(data not shown). Western analysis indicated that theTransgenic syndecan-1 misexpressed in the hypothala-
mus causes hyperphagia apparently by potentiating the size of the syndecan-3 HS chains are indistinguishable
from those on hypothalamic syndecan-1 in syndtrophinaction of Agrp on MC-4R. We considered the possibility
that the transgenic syndecan-1 interfered with a nor- mice. In contrast to hypothalamic transgenic syndecan-1,
one-third of hypothalamic syndecan-3 was soluble, andmally functioning modulator of feeding behavior, and
evaluated whether syndecan-3, known to be in the brain, the remainder was sedimentable, suggesting both shed
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Figure 5. Syndecan-3 Modulates Feeding Behavior in Wild-Type Mice
(a) Syndecan-3 is normally expressed in hypothalamic nuclei that regulate feeding behavior. Immunohistochemical analysis of syndecan-3
and oxytocin protein expression in the hypothalamus of 3-month-old (/) mice. Data presented are representative section from the anterior
(panels A and B) or posterior (panel C) hypothalamus. Panel B is an adjacent section to Panel A and demonstrates expression of the anterior
hypothalamic marker oxytocin. lha, lateral hypothalamic area; pev, periventricular nuclei; pvn, paraventricular nuclei; 3V, third ventricle. Scale
bar  250 m.
(b) Syndecan-3 in the hypothalamus of/mice is comprised of both intact transmembrane HSPG and soluble ectodomain. Soluble (100,000
g supernatants, S) or membrane bound (100,000  g pellets, P) HSPGs were either untreated (No Rx) or digested with heparin lyase II and
chondroitinase ABC (Lyase). Samples were blotted with affinity-purified syndecan-3 specific antibody. Approximately 5 g total protein was
applied per lane.
(c) Syndecan-3 null mice have no detectable syndecan-3 proteoglycan. Hypothalamic PGs from 3-month-old syndecan-3 (synd-3) null (	/	)
and / mice were partially purified by the phenol/GuHCl method, and blotted using affinity-purified mouse syndecan-3 antibodies.
(d) Hypothalamic syndecan-3 levels increase in response to food deprivation. Six-week-old C57Bl/6J male mice were either fed ad libitum or
food-deprived for 24 hr with free access to water. The mice were then sacrificed, each hypothalamus rapidly removed, and individually
extracted. The proteoglycans were partially purified using phenol/GuHCl method, digested with heparin lyase II and chondroitinase ABC, and
the HSPGs analyzed by Western analysis using (1) mAb 3G10, which reacts with a lyase-produced HS epitope on HSPG core proteins, or (2)
affinity purified antibody specific for mouse syndecan-3.
(e) Syndecan-3 null mice show diminished reflex hyperphagia compared to their control / littermates. Three month old male syndecan-3
null and wild-type littermates were individually housed and acclimatized for a one week period. Mice were weighed and food deprived for 16
hr beginning with the onset of the dark cycle. The next day, mice were weighed, a preweighed amount of chow was provided, and chow
weighed at the indicated times. Data presented are mean  SEM, syndecan-3 null (n  7) and / (n  5), and are combined from two
independent experiments.
ectodomain and membrane-bound forms of syndecan-3 and detected by either an antibody specific for the
heparin lyase generated epitope, mAb 3G10 (Figure 5d(Figure 5b).
We hypothesized that if hypothalamic syndecan-3 is panel 1) or an affinity-purified syndecan-3 antibody (Fig-
ure 5d, panel 2). The bands detected correspond inphysiologically involved in regulating feeding behavior, its
level would change with feeding as do various hypothala- PAGE mobility to syndecan-3 and to various glypicans;
no other HSPGs were detected (Figure 5d, panel 1).mic peptides that modify feeding behavior (Schwartz et
al., 2000). Hypothalamic HSPGs extracted from un- Remarkably, food deprivation increased hypothalamic
syndecan-3 levels more than 4-fold above that of adrestricted and food deprived (24 hr) wild-type C57Bl/6J
mice were heparin-lyase treated, subjected to PAGE, libitum fed mice, while the levels of the putative glypi-
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Table 2. Induction of Hypothalamic Syndecan-3 Expression by 24 decan-3 null mice and / littermates (29.6 g  0.8 g,
hr Food Deprivation n  7, and 30.5 g  0.1 g, n  5, respectively) were
food deprived for 16 hr, weighed, refed, and food con-Change in proteoglycan level*
Food Deprived/Fed sumption monitored (Figure 5e). The rate and extent
of reflex hyperphagia in the syndecan-3 null mice wasSyndecan-3 Glypicans
significantly reduced compared to their/ littermates.
Experiment 1† 4.6  0.9 (n  5)1 0.5  0.1 (n  5) The reduced hyperphagia in syndecan-3 null mice was
Experiment 2‡ 3.2  0.9 (n  4)2 0.9  0.2 (n  4)
not due to differential weight loss during food depriva-
*Summary of data presented in Figure 5c† and other data‡ quanti- tion (approximately 3 g in both groups).
tated from mAb 3G10 antibody immunoblots.
1p  0.05, 2p  0.005
Discussion
Our finding that transgenically expressed hypothalamiccans were unchanged (Table 2). The elevated levels of
syndecan-3 fall with refeeding (data not shown). Be- syndecan-1 causes hyperphagia and obesity has uncov-
ered a physiological role for syndecan-3 in the modula-cause the GAG-free soluble ectodomain binds poorly
to the cationic membrane used for the blots, the levels tion of feeding behavior. We find that syndecan-3 is
expressed in hypothalamic feeding centers, is both atseen here predominantly represent cell surface synde-
can-3. Thus, hypothalamic cell surface syndecan-3 lev- the cell surface and shed as the soluble ectodomain,
its levels change in response to food deprivation, andels change with food deprivation and refeeding in a
manner similar to Agrp and other hypothalamic modifi- its deficiency results in markedly reduced reflex hyper-
phagia after food deprivation. Our results add syndecan-3ers of feeding behavior.
Because syndecan-3 is induced upon food depriva- to the panoply of factors involved in the control of body
weight. This multiplicity of regulatory peptides and re-tion, we evaluated whether its loss, in null mice, would
modulate feeding behavior. Syndecan-3 null mice are ceptors likely reflects the evolutionary importance of
body weight maintenance, but can obscure the effectsviable, born in expected Mendelian ratios, are healthy,
and show no apparent morphological, histological, or of manipulating any single signaling system (Palmiter et
al., 1998).behavioral abnormalities. However, they exhibit marked
changes in hippocampal long-term potentiation and in Transgenic expression of syndecan-1 results in obese
mice that resemble mice with reduced action of MSH.spatial memory. These mice will be described in a sepa-
rate publication (M.K., I. Pavlov, V. Voikar, S. Lauri, A. In these mice, obesity develops after they reach matu-
rity, corticosterone levels are normal, lean body massHeinola, M. Lasko, T. Taira, and H.R.). Supplemental
information on the generation of the mice is available is unaffected, and body size slightly larger than in wild-
type mice (Yen et al., 1994). Moreover, the syndecan-1on the Cell website at http://www.cell.com/cgi/content/
full/106/1/105/DC1). Additionally, we determined that no transgene is expressed in a pattern similar to MC-4R
and Agrp neurons and their projections (Bagnol et al.,syndecan-3 was detected in the hypothalamus of synde-
can-3 null mice (Figure 5c). To evaluate the role of synde- 1999; Mountjoy et al., 1994). This hypothalamic expres-
sion pattern may result from the presence of a bindingcan-3 on feeding behavior, male three-month-old syn-
Figure 6. Model of Hypothalamic Postsynaptic Membranes Depicting the Role of Syndecans in Modulating Feeding Behavior
(a) In syndtrophin mice, misexpressed cell surface syndecan-1 persists at relatively high levels because of its inability to be shed. This results
in constant potentiation of the activity of an antisatiety peptide, presumably Agrp at the MC-3R or -4R, producing continuous feeding and,
ultimately, severe obesity.
(b) In contrast, in wild-type mice, cell surface syndecan-3 is induced in response to food deprivation and its ectodomain is shed in response
to feeding. Thus, increased levels of cell surface syndecan-3 would potentiate the activity of an antisatiety peptide, presumably Agrp, and
enhance feeding, whereas the shedding of the syndecan-3 ectodomain would remove this stimulus and reduce feeding. Syndecan core protein
is presented as gray line and the covalently attached heparan sulfate chains presented as black squiggly lines.
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site, in the vector, for the ISL-1 transcription factor. ISL-1 evidence has implicated syndecan-3 in the formation
and guidance of CNS axons, in part by interacting withis expressed similarly as the syndecan-1 transgene in
both brain and somatic tissues (Thor et al., 1991). HB-GAM, an extracellular neurite outgrowth promoting
peptide (Raulo et al., 1994). Syndecan-3 shares the
C-terminal PDZ domain binding sequence EFYA with allAction of Cell Surface Syndecans
other syndecans and various synaptic receptors, en-Syndecans bind to the MSH antagonists ASP and Agrp
abling them to bind CASK and other submembranousvia their HS chains. Both cell surface syndecan-1 and
scaffolding proteins enriched in postsynaptic densities-3 potentiate the inhibitory action of Agrp on the MC4-R,
(Kennedy, 2000). Moreover, the accumulation and distri-consistent with the physiological data implicating re-
bution of certain neuropeptides during CNS develop-duced MSH action in syndtrophin mice and with the
ment is known to depend on synaptic cell surfacegenetic interaction between syndtrophin and lethal yel-
HSPGs (Loeb et al., 1999). Finally, because there is nolow mice. The binding data suggest that the syndecan
uptake mechanism or degrading system for neuropep-HS chains bind the N-terminal region of Agrp (Figure 3a),
tides in synaptic clefts (Kandel and Abel, 1995), ectodo-leaving the conserved C-terminal region free to interact
main shedding would be a reasonable means of signalwith MC-3 or 4R, displace MSH, and regulate feeding
termination. Based on our evidence that syndecan-1behavior (Hagan et al., 2000; Kiefer et al., 1998; Mizuno
and -3 likely regulate MC-3R and -4R neurons, we sug-and Mobbs, 1999; Yang et al., 1999). These data are
gest that cell surface HSPGs play regulatory roles in aconsistent with results that implicate the N-terminal re-
variety of peptidergic synapses in the CNS.gion of the agouti proteins as the regulatory site (He et
al., 2001; Nagle et al., 1999). By analogy to the corecep-
Experimental Procedurestor action of HSPGs in the formation of FGF-FGFR com-
plexes (Rapraeger et al., 1991; Steinfeld et al., 1996),
Construction of Syndecan-1 Transgenic and Syndecan-3HSPG binding to Agrp likely augments formation of an
Null Mice
Agrp-MC-3R or -4R complex, thus reducing access of Syndecan-1 Transgenics
MSH to its receptor. A full-length mouse syndecan-1 cDNA and mutant constructs were
Syndecans must be at the cell surface to alter feeding inserted into the HindIII site of the pCDNA3 plasmid (Invitrogen).
Endonucleases MluI and DraIII were used to isolate a 2.5 kB frag-behavior. Transgenically expressed hypothalamic syn-
ment containing 660 bp of the CMV promoter, the syndecan-1 cDNAdecan-1 persists at the cell surface because it is not
including 203 bp of its 3
UTR, and the 3
UTR and polyadenylationshed, resulting in continual inhibition of MSH action
signal of bovine growth hormone. The fragment was injected into
(Figure 6). The level of transgenically expressed cell sur- fertilized FVB oocytes and implanted into recipient pseudopregnant
face syndecan-1 correlates with weight gain (Figure 1b), mice. Using PCR, a stop codon at aa S19 or Q245 was inserted for
whereas transgenically expressed constitutively shed the nontranslatable or constitutive shed (CS) mutants, respectively.
Multistep PCR replaced the juxtamembrane amino acid residuessyndecan-1 is without effect on body weight (Figure 4c).
E238GATGASQSLLDTKE252 with the analogous region of humanIn contrast, hypothalamic syndecan-3 is both at the cell
CD4, amino acid residues VKVLPTWSTRVQPMA for the uncleavablesurface and shed as a soluble ectodomain, and its levels
(UC) mutant. Transgenic offspring were identified initially by South-
at the cell surface vary in response to feeding state. We ern blot analysis and routinely by PCR.
propose that feeding is enhanced by increased levels of Syndecan-3 Null
cell surface syndecan-3, and reduced when syndecan-3 Genomic sequence corresponding to syndecan-3 cDNA (Carey et
al., 1997) was cloned from 129SV mouse genomic library (Stra-is shed from the cell surface following food intake.
tagene). An 8.2 kb fragment containing exons 3–5 and a plasmidThe processes responsible for the changes in synde-
containing a PKG-neo and TK cassettes was used for generationcan-3 level are unknown. However, brain syndecan-3
of the targeting construct. A region from ApaI restriction site in exon
has been shown to be induced, e.g., in long term potenti- 3 to BamHI restriction site downstream of the exon 4 was replaced
ation (Lauri et al., 1998). Hypothalamic syndecan-3 is by a PKG-neo cassette and the TK cassette was located to the 5

found as a mixture of soluble and cell surface HSPG, end of the construct. Linearized targeting construct was electropor-
ated into CJ7 ES cells (Swiatek and Gridley, 1993) and clones resis-likely reflecting its release from cell surfaces by ectodo-
tant to G418 and gancyclovir were selected. Targeting was con-main shedding (Carey et al., 1997). Syndecan ectodo-
firmed by Southern hybridization with flanking probes. Cells frommain shedding is highly regulated and involves cell sur-
two independent clones were injected into C57BL/6 blastocysts.
face receptors and various kinases impinging on a zinc Chimeric animals were crossed to C57BL/6. Syndecan-3 gene prod-
metalloprotease (Fitzgerald et al., 2000). Multiple shed- uct was not detected in 	/	 animals when tested by Northern
ding enzymes have been identified to date and some hybridization, immunostaining, or Western analyses (Figure 5c).
have been shown to exhibit substrate specificity. Thus,
Tissue Proteoglycan Extraction and Analysisit is likely that the shedding enzyme that cleaves synde-
Tissues were isolated and homogenized using a polytron in a buffercan-3 does not recognize syndecan-1 (Figures 4b and
containing 50 mM mannitol, 50 mM Tris (pH 7.4), 5 mM EDTA, and5b). We speculate that activation of MC-3R or -4R neu-
1 mM PMSF. Homogenates were centrifuged at 1000  g for 10
rons in response to a postprandial signal (e.g., insulin min and the supernatant spun at 100,000  g for 30 min. The sedi-
or amylin) causes a syndecan-3 specific metallopro- ment was extracted for 1 hr at 4C in a buffer containing 50 mM
tease to release the ectodomain from the cell surface Tris (pH 7.4), 150 mM NaCl, 1% NP-40, 1% Tween-20, 0.5% Triton
X-100, 5 mM EDTA, and 1 mM PMSF and centrifuged at 100,000 (Figure 6).
g for 30 min to collect a detergent-soluble fraction. The supernatants
were partially purified over Q-Sepharose columns and concentratedSyndecans as Regulators
by three successive precipitations in 3 volumes of 96% ethanol
of Peptidergic Synapses containing 1.7% KAcetate. Samples were either untreated or di-
More generally, our data add to the emerging evidence gested with chondroitinase ABC, heparin lyase I, and heparin lyase
III prior to PAGE. After transfer, immunoreactivity was detectedthat syndecans are important in CNS synapses. Prior
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using monoclonal antibody 281-2 and the ECL method (Amersham). fluorophore Texas Red at 10 g/ml (Jackson ImmunoResearch Lab-
oratories, Inc.). Confocal images were collected on a Zeiss LSM410/Alternatively, tissues were homogenized and extracted in buffer
containing 0.32 M sucrose, 10 mM HEPES (pH 7.4), 5 mM EDTA, 1 Zeiss Axiovert 135TV system. Fluorescein signal (488 nm) and Texas
Red (586 nm) were collected sequentially on separate channels tomM EGTA, and Complete protease cocktail (Boehringer Mann-
heim). Homogenates were centrifuged in at 5,000  g to remove avoid bleedthrough. Digital reconstruction and image processing
was performed using Photoshop 6.0 (Adobe, Inc.).nuclei and cell debris, pellets were reextracted, and the superna-
tants centrifuged at 100,000  g for 1 hr at 4C. The supernatants Syndecan-3 expression in wild-type mice was performed as fol-
lows: adjacent sections were deparaffinized and blocked as de-were partially purified over Q-Sepharose. The pellets were extracted
in a 4 Guanidine-HCl/50% buffered phenol/0.2 sodium acetate (pH scribed above. Primary antibodies were diluted appropriately in
blocking buffer and applied to the adjacent sections overnight at4.5) and extracted as described below.
4C. The affinity-purified rabbit polyclonal antibody against the mu-
rine syndecan-3 ectodomain was used at a concentration of 2 g/Hypothalamic Proteoglycan Extraction and Analysis
ml. The affinity purified rabbit anti-mouse oxytocin (Phoenix Phar-Each individual hypothalamus was dissected from surrounding tis-
maceuticals, Inc.) was used at 10 g/ml. The primary antibodiessue (approximately 20 mg wet weight), extracted in 1 ml 4 M Guani-
were detected using a rabbit IgG-specific secondary antibody con-dine-HCl, 50% buffered saturated phenol, 0.2 M NaAcetate (pH 4.5),
jugated to biotin at 0.5 g/ml and the signal amplified using theand the samples rapidly vortexed for one minute. To this extract,
ABC-HRP method with diaminobenzidine/nickel according to thea 0.2 ml CHCl3/Isoamyl alcohol (IAA) was added and the sample
manufacturer’s instructions (Vector Laboratories, Inc.). Images werecentrifuged at 14,000  g for 10 min to form aqueous and phenol
collected by digital acquisition on a Zeiss Axioskop 2 system andphases. The phenol phase contains protein while the aqueous and
processed using Zeiss OpenLab software and Photoshop 6.0.interphase contain proteoglycans and nucleic acids. The phenol
In situ hybridization was performed using nonisotopic digoxi-phase was discarded and the aqueous and interphase were reex-
genin-labeled riboprobes on coronal brain sections. Antisense ribo-tracted twice in phenol and CHCl3/IAA and subsequently precipi-
probe specific for the murine syndecan-1 transcript produced spe-tated with 3 volumes of 96% ethanol, 1.7% potassium acetate.
cific staining relative to a control sense riboprobe controls, whichPellets were resuspended in Tris-buffered saline containing 0.5%
gave no signal. To visualize the probe, an anti-digoxigenin alkalineTriton X-100 and reprecipitated several times to remove all traces
phosphatase conjugated antibody was applied to the sections andof guanidine-HCl. Samples were digested with chondroitinase ABC
the signal was detected by an 8.5 hr incubation with the BM purpleand heparin lyase II and analyzed on SDS-PAGE. After transfer to
substrate (Roche Biochemicals). Microscopy was performed on thecationic nylon membranes (Immobilon N, Millipore Corp), HSPGs
Zeiss Axioskop 2 as described above.were immunodetected using affinity-purified mouse syndecan-3 an-
tibody and anti-stub antibody (3G10) kindly provided by Dr. Guido
Analysis of Plasma ConstituentsDavid (David et al., 1992). The GAG-free syndecan-3 ectodomain
Blood from living ad libitum fed mice was collected by puncture ofbinds poorly to this and other types of membranes. Quantitation
the retro-orbital sinus with heparinized capillary tubes in siliconizedwas performed using NIH Image version 1.60b7.
microfuge tubes. Glucose levels were measured with 5 l plasma
using the glucose hexokinase assay (Glucose [HK] reagent [Sigma]).Feeding Studies
Insulin and leptin levels were measured with 25l plasma by specificThe food intake was measured in 6-week- and 6-month-old FVB or
radio-immunoassay with recombinant insulin and recombinant lep-C57Bl/6J mice housed individually. After one week of acclimatiza-
tin as standards (Linco Research, Inc.). Corticosterone levels weretion, mice were fed ad libitum for a two week period. Food was
measured with 5 l plasma by a specific radio-immunoassay (ICNweighed daily to monitor for spillage. For food restriction studies,
Diagnostics).mice at 6 weeks of age were housed individually and provided an
equivalent amount of chow (5.5 g chow/day) as consumed by the
Ligand Blot Analysiswild-type FVB mice, determined by the ad libitum food intake stud-
Varying concentrations of each peptide were bound to nitrocelluloseies. Refeeding studies were performed on 12-week-old male mice
membranes and confirmed by Ponceau S staining of the membrane.acclimatized and housed as above. Food was removed for 16 hr,
The membrane was then blocked with 1 mg/ml BSA in phosphate-then the mice were refed and the chow remaining was weighed at
buffered saline (PBS) for 1 hr at room temperature. [35S]syndecanthe indicated times. Mice were weighed before initiation of food
extracellular domain (5000 cpm/ml) was added, the membrane wasdeprivation and of refeeding.
incubated overnight at 4C, washed several times with PBS, dried,
and autoradiographed.Immunohistochemical and In Situ Analysis
Mice were sacrificed by cervical dislocation and fixed by perfusion
Melanocortin-4 Receptor Activation and Inhibition Analysiswith 4% paraformaldehyde in phosphate buffered saline (PBS). The
HEK293 cells expressing human MC-4R were incubated with Agrpbrains were dissected out, postfixed overnight at 4C in 4% para-
(1 nM) for 30 min and then stimulated with either 100 nM MSH orformaldehyde/PBS, dehydrated into xylene through a graded etha-
NDP-MSH and incubated an additional 30 min. Culture media werenol series and embedded in Paraplast paraffin (Oxford Laboratories).
removed, 0.5 M formic acid was added to the cells, and samplesSections were cut at 10 m on a Reichert-Jung 2030 microtome
analyzed using an cAMP EIA kit (Stratagene). To evaluate the actionand stored at 4C.
of syndecan-1 or -3, cells were transiently transfected with synde-Immunohistochemical analysis of syndecan-1 and oxytocin pro-
can-1, -3, or control cDNA (nontranslatable syndecan-1 construct)tein expression patterns was performed as follows: sections were
using the Lipofectamine Reagent (GibcoBRL) and assayed as above.deparaffinized in xylene and rehydrated into PBS through a graded
Assays were performed in triplicate.ethanol series. Sections were blocked 1 hr in blocking buffer (0.5%
caesin [I-Block, Tropix, Inc.] in PBS-T [PBS and 0.1% Tween-20]).
Statistical EvaluationPrimary antibodies were diluted appropriately in blocking buffer
All values are means /	 SEM. Two-tailed Student’s t test wasand applied to the sections overnight at 4C. The rat monoclonal
used to test for the significance of differences.antibody 281-2 against the murine syndecan-1 ectodomain (Jalka-
nen et al. 1985) was used at a concentration of 2.24 g/ml. The
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